Entain (ENT) Stock Forecast & Price Target

GBX 735.40 +0.60 (+0.08%)

(As of 05:42 AM ET)

Entain - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 7 Analyst Ratings

Sell
1

Hold
3

Buy
3

Based on 7 Wall Street analysts who have issued ratings for Entain in the last 12 months, the stock has a consensus rating of "Hold." Out of the 7 analysts, 1 has given a sell rating, 3 have given a hold rating, and 3 have given a buy rating for ENT.

Consensus Price Target

GBX 1,025.80

According to the 7 analysts' twelve-month price targets for Entain, the average price target is GBX 1,025.80. The highest price target for ENT is GBX 1,140, while the lowest price target for ENT is GBX 820. The average price target represents a forecasted upside of 39.49% from the current price of GBX 735.40.

Get the Latest News and Ratings for ENT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Entain and its competitors.

ENT Analyst Ratings Over Time

Type	Current Forecast 11/22/23 to 11/21/24	1 Month Ago 10/23/23 to 10/22/24	3 Months Ago 8/24/23 to 8/23/24	1 Year Ago 11/22/22 to 11/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	4 Buy rating(s)	5 Buy rating(s)	8 Buy rating(s)
Hold	3 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	GBX 1,025.80	GBX 1,029.80	GBX 1,143.17	GBX 1,570.17
Consensus Rating	Hold	Hold	Moderate Buy	Buy

Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address.

ENT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ENT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Entain Stock vs. The Competition

Type	Entain	Consumer Cyclical Companies
Consensus Rating Score	2.29	2.65
Consensus Rating	Hold	Moderate Buy
News Sentiment Rating	Positive News See Recent ENT News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
11/7/2024	Berenberg Bank 2 of 5 stars	Lower Target	Neutral	GBX 1,030 ➝ GBX 1,010	+35.03%
9/11/2024	JPMorgan Chase & Co. 3 of 5 stars	Reiterated Rating	Neutral
9/9/2024	Shore Capital 1 of 5 stars	Reiterated Rating	Buy
6/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	GBX 1,140	+70.15%
4/18/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	GBX 1,089	+33.19%
2/6/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Equal Weight	GBX 1,120 ➝ GBX 1,070	+10.84%
Get the Latest News and Ratings for ENT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Entain and its competitors with MarketBeat's FREE daily newsletter.
11/27/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Sell	GBX 1,450 ➝ GBX 820	-2.38%
9/27/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy	GBX 2,200 ➝ GBX 1,600	+69.31%
3/9/2023	Numis Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	GBX 1,900	+41.97%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:10 AM ET.

ENT Forecast - Frequently Asked Questions

: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Entain is GBX 1,025.80, with a high forecast of GBX 1,140 and a low forecast of GBX 820.
: 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Entain in the last twelve months. There is currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ENT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ENT, but not buy additional shares or sell existing shares.
: According to analysts, Entain's stock has a predicted upside of 39.49% based on their 12-month stock forecasts.
: Entain has been rated by research analysts at Berenberg Bank, JPMorgan Chase & Co., and Shore Capital in the past 90 days.
: Analysts like Entain less than other "consumer cyclical" companies. The consensus rating for Entain is Hold while the average consensus rating for "consumer cyclical" companies is Moderate Buy. Learn more on how ENT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

This page (LON:ENT) was last updated on 11/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Entain (ENT) Stock Forecast & Price Target